ERBB2 and cancer: Breast cancer (BC) is the most frequently diagnosed malignancy and the leading cause of cancer mortality in women1, with estrogen-receptor-positive (ER+), human epidermal growth factor receptor 2 negative (HER2–) BC being the most common BC subtype2.